Effect of SIMBRINZA™ As an Added Therapy to a Prostaglandin Analogue

Conditions:   Ocular Hypertension;   Open Angle GlaucomaInterventions:   Drug: Brinzolamide 1%/brimonidine 0.2% ophthalmic suspension;   Drug: Vehicle;   Drug: Prostaglandin analogue ( TRAVATAN Z® , LUMIGAN®, XALATAN®)Sponsors:   Alcon Research;   Alcon ResearchNot yet recruiting - verified September 2013
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials